Single total dose infusion of ferumoxytol (1020 mg in 30 minutes) is an improved method of administration of intravenous iron

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial

(2018) N. Franklin Adkinson et al.   AMERICAN JOURNAL OF HEMATOLOGY

Intravenous iron: out of sight, out of mind

(2018) Michael Auerbach et al.   Lancet Haematology

The available intravenous iron formulations: History, efficacy, and toxicology

(2017) Michael Auerbach et al.   Hemodialysis International

Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron

(2016) Iain C. Macdougall et al.   AMERICAN JOURNAL OF NEPHROLOGY

Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management

(2014) D. Rampton et al.   HAEMATOLOGICA

Hypersensitivity from Intravenous Iron Products

(2014) Andreas J. Bircher et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min

(2013) Michael Auerbach et al.   AMERICAN JOURNAL OF HEMATOLOGY

A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications

(2011) Markus R. Jahn et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Ferumoxytol for the treatment of iron deficiency

(2011) Mitchell H Rosner et al.   Expert Review of Hematology